Neurostar RTMS denied due to quantity / dose limits by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for neurostar rtms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Applies Quantity Limits to NeuroStar TMS — and How to Appeal

NeuroStar TMS involves a course of treatment sessions delivered over several weeks, and UnitedHealthcare's coverage policy specifies a maximum number of sessions (or treatment courses) it will cover within a defined period. When your prescribing psychiatrist recommends a number of sessions that exceeds UHC's predetermined limit — or recommends a second course of treatment when the policy allows only one — a quantity-limit denial is issued. This is an administrative coverage restriction and does not mean UHC has determined TMS is clinically wrong for you.

### Why This Denial Is Appealable

Quantity-limit restrictions must be based on a clinical rationale, and that rationale must be disclosed to you upon request. If your psychiatrist has determined that additional sessions or a repeat course are medically necessary based on your individual clinical response and ongoing need, the plan is required to evaluate that judgment. Under ACA Section 2719 and ERISA Section 503, you are entitled to a full-and-fair review and, if that fails, independent external review by a clinically qualified reviewer whose decision is binding on UHC.

### Your Appeal Timeline

• Internal appeal: File by the deadline on your denial letter. Pre-service appeals require a decision within 30 days; post-service within 60 days.
• External review: After an adverse internal decision, you generally have four months to request independent external review. The decision is binding on UHC.
• Expedited option: Available within 72 hours if your health would be seriously jeopardized by standard timing.

### Documentation to Gather

1. Treatment response documentation — chart notes from each completed TMS session or course, including validated symptom-scale scores recorded before and after treatment, showing your clinical trajectory. 2. Ongoing or residual symptom documentation — current psychiatric notes documenting persistent symptoms, functional impairment, and the clinical rationale for continued or repeated treatment. 3. Prior-treatment context — a summary of prior medications and other treatments tried, establishing why TMS remains the appropriate treatment modality rather than switching to a different approach. 4. Prescriber medical-necessity letter — a specific letter from your psychiatrist explaining why the number of sessions requested exceeds the standard limit, what clinical factors support this recommendation, and what the anticipated harm of stopping at the limit would be.

### Criteria-Mapping Structure

Request UHC's published TMS coverage policy and identify the specific quantity-limit provision and its stated clinical rationale. Also review the NeuroStar FDA clearance documentation for any reference to standard treatment course parameters. In your appeal, address the policy's limit directly: acknowledge the limit, cite the specific clinical facts in your chart that establish medical necessity for additional treatment, and attach the supporting documentation as labeled exhibits. Referencing applicable psychiatric society guidance (e.g., from the APA or relevant body) on repeat or extended TMS courses can further support the medical-necessity argument.